Chemoinformaics analysis of Bersaldegenin-3-Acetate
| Molecular Weight | 474.55 | nRot | 3 |
| Heavy Atom Molecular Weight | 440.278 | nRig | 29 |
| Exact Molecular Weight | 474.225 | nRing | 5 |
| Solubility: LogS | -3.086 | nHRing | 1 |
| Solubility: LogP | 0.587 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 72.507 |
| nHD | 3 | BPOL | 40.185 |
| QED | 0.448 |
| Synth | 5.055 |
| Natural Product Likeliness | 2.83 |
| NR-PPAR-gamma | 0.955 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.906 |
| Pgp-sub | 0.502 |
| HIA | 0.798 |
| CACO-2 | -5.016 |
| MDCK | 0.0000474 |
| BBB | 0.997 |
| PPB | 0.655192 |
| VDSS | 0.583 |
| FU | 0.30772 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.172 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.189 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.478 |
| CYP3a4-sub | 0.384 |
| CL | 4.671 |
| T12 | 0.079 |
| hERG | 0.137 |
| Ames | 0.025 |
| ROA | 0.984 |
| SkinSen | 0.056 |
| Carcinogencity | 0.849 |
| EI | 0.007 |
| Respiratory | 0.718 |
| NR-Aromatase | 0.838 |
| Antiviral | Yes |
| Prediction | 0.809857 |